The Scripps Translational Science Institute (STSI) was awarded $34 million in renewed funding to advance genomic and digital technologies in clinical care.

The five-year grant is the third such award to STSI from the National Institutes of Health. As part of the funding, STSI has formed a new partnership with Rady’s Children’s Institute for Genomic Medicine, dedicated to ultra-rapid, whole-genome sequencing programs in acutely ill infants to speed up diagnoses.

STSI is part of The Scripps Research Institute.

“We are thrilled to have the NIH’s continued support for our efforts to advance individualized medicine, both in care of patients and in training of young physicians and scientists,” says Eric Topol, director of STSI and an executive vice president at The Scripps Research Institute.

The $34 million renewal also includes a drug discovery collaboration between STSI and California Institute for Biomedical Research, a Scripps Research Institute-affiliated organization that focuses on transforming basic research into new medicines that address unmet medical needs.

In addition, it was recently announced STSI will head key aspects of a national research program called All of Us, with the ambitious goal of obtaining health, behavioral and genomics information from a representative sample of the American population.

Health data from a large and diverse group of people will enable scientists to study how different factors — from genetics to exercise habits — impact a person’s health.